CD274 and esophageal squamous cell carcinoma: In ESCC, several studies demonstrated patients with high PD-L1 expression obtained more benefit from anti-PD-1/PD-L1 therapy plus chemotherapy compared with chemotherapy alone than patients with low PD-L1 expression [14–19, 21, 25, 26].